HALOZYME THERAPEUTICS INC Uncategorized Contracts & Agreements
26 Contracts & Agreements
- Letter Agreement Amending Exercise Period for Employee Option (Filed With SEC on August 8, 2023)
- Form of Restricted Unit Agreement (2021 Plan Sell-to-Cover updated May 2023) (Filed With SEC on August 8, 2023)
- Form of Capped Call Confirmation (Filed With SEC on August 18, 2022)
- Description of Securities (Filed With SEC on February 22, 2022)
- Form of PSU Agreement (Filed With SEC on February 23, 2021)
- Description of Securities (Filed With SEC on February 24, 2020)
- Entry into Material Definitive Agreements (Filed With SEC on June 16, 2011)
- Entry into Material Definitive Agreements (Filed With SEC on June 16, 2011)
- Develop our own proprietary products based on our PH20 enzyme and other new molecular entities (Filed With SEC on March 11, 2011)
- Financial Statements (Filed With SEC on August 7, 2009)
- Financial Statements (Filed With SEC on August 7, 2009)
- Financial Statements (Filed With SEC on August 7, 2009)
- Exhibit No (Filed With SEC on June 23, 2009)
- Current assets (Filed With SEC on November 7, 2008)
- Cash and cash equivalents (Filed With SEC on May 9, 2008)
- Cash and cash equivalents (Filed With SEC on May 9, 2008)
- Cash and cash equivalents (Filed With SEC on May 9, 2008)
- Develop our own proprietary products based on our PH20 enzyme and other new molecular entities (Filed With SEC on March 14, 2008)
- Current assets (Filed With SEC on August 8, 2006)
- Current assets (Filed With SEC on August 8, 2006)
- Current assets (Filed With SEC on August 8, 2006)
- Current assets (Filed With SEC on August 8, 2006)
- HALOZYME THERAPEUTICS, INC. (Filed With SEC on May 8, 2006)
- Exhibit No (Filed With SEC on March 30, 2005)
- Exhibit No (Filed With SEC on March 30, 2005)
- Exhibit No (Filed With SEC on February 22, 2005)
